Testing a protein marker for adenomyosis diagnosis
Part of Women’s health & pregnancy clinical trials.
This study measures a protein called L-PGDS (lipocalin-type prostaglandin D synthase) in blood, urine, and tissue samples to see if it can help diagnose adenomyosis (a condition that causes heavy periods and pelvic pain). Researchers are comparing levels in women with and without adenomyosis who are having a hysterectomy, as well as in women without symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 28 and 57 years old (if you have adenomyosis or another uterine condition) or 18 to 57 (if you are in the control group).
- You have not gone through menopause.
- You are scheduled for a hysterectomy that removes the uterus but leaves your ovaries (for adenomyosis groups) OR you are having infertility treatment and need an ultrasound (for control group).
- You have no history of autoimmune disease, asthma, sleep apnea, or cancer.
- You have not taken pain relievers like ibuprofen, naproxen, aspirin, or steroids in the last 2 weeks.
- You are not currently using hormonal birth control (like the pill or patch).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects tissue samples during surgery to create a detailed map of genes in endometriosis. It may help researchers understand why some people have more severe symptoms.
This study collects blood and small tissue samples during planned gynecological surgery to better diagnose endometriosis and predict its course. It may help future patients by making diagnoses and outlook more accurate.
This study looks at how well different methods (clinical exams, imaging, and tissue analysis after surgery) can diagnose adenomyosis. It is for women who have heavy bleeding and pain, have completed their families, and have decided to have a hysterectomy.
This study uses advanced imaging and lab tests to better diagnose endometriosis and adenomyosis. Participants must be of European descent, have a clear ultrasound diagnosis, and be undergoing IVF (in vitro fertilization) — specifically a first or second cycle if they have both conditions, or a frozen embryo transfer if they have just one.
This early-stage study tests a new treatment for adenomyosis, a condition that can cause heavy bleeding and pelvic pain. The goal is to find a way to ease these symptoms, and it may be an option if you are between 30 and 50, have adenomyosis, and are not planning to become pregnant.
This study tests whether ultrasound can more accurately diagnose adenomyosis, a condition where the inner lining of the uterus grows into the muscle wall. It may help you get a clearer diagnosis without more invasive tests.
Hear when a new Adenomyosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.